Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Cash Flows

v3.22.4
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 311,440 $ 354,108 $ 108,013
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, Amortization And Non-Cash Lease Expense 117,399 115,571 146,601
Accounts Receivable, Credit Loss Expense (Reversal) (2,044) (10,758) 19,156
Gain (Loss) on Disposition of Assets (38,194) (1,233) (31,342)
Deferred income taxes (8,118) (9,798) (11,263)
Share-based Payment Arrangement, Noncash Expense 21,021 19,126 17,778
Changes in operating assets and liabilities:      
Increase (Decrease) in Accounts Receivable (64,495) (31,622) 22,885
Increase (Decrease) in Inventories (399,851) (100,261) 64,884
Increase (Decrease) in Prepaid Expense and Other Assets (25,749) (24,858) 33,712
Increase (Decrease) in Prepaid Expense and Other Assets 25,749 24,858 (33,712)
Increase (Decrease) in Other Noncurrent Assets 2,475 (1,231) 21,224
Increase (Decrease) in Accounts Payable 40,429 75,513 (49,275)
Increase (Decrease) in Accrued Liabilities 20,683 66,457 (52,115)
Increase (Decrease) in Income Taxes Payable (5,871) (15,248) 9,082
Increase (Decrease) in Other Operating Assets and Liabilities, Net 62,749 85,176 52,112
Increase (Decrease) in Other Noncurrent Liabilities (3,055) (1,112) 8,613
Net cash provided by operating activities (25,241) 354,406 276,077
Cash flows from investing activities:      
Payments to Acquire Short-term Investments (44,876) (130,191) (35,044)
Proceeds from Sale, Maturity and Collection of Short-term Investments 176,083 1,184 36,631
Payments to Acquire Productive Assets 58,467 34,744 28,758
Net cash used in investing activities 72,740 (163,751) (27,171)
Cash flows from financing activities:      
Proceeds from Lines of Credit 52,918 38,334 402,422
Repayments of Lines of Credit (52,979) (38,156) (403,146)
Payment of line of credit issuance fees 604 0 3,278
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 6,588 28,783 6,919
Payment, Tax Withholding, Share-based Payment Arrangement (4,229) (5,812) (4,533)
Payments for Repurchase of Common Stock (287,443) (165,415) (132,889)
Payments of Dividends 75,082 68,623 17,195
Net cash used in financing activities (360,831) (210,889) (151,700)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (19,831) (7,087) 7,510
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total (333,163) (27,321) 104,716
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance 763,404 790,725  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 430,241 763,404 790,725
Supplemental disclosures of cash flow information:      
Income Taxes Paid 92,110 129,483 14,687
Supplemental disclosures of non-cash investing activities:      
Capital expenditures incurred but not yet paid 11,103 5,853 3,831
Cash and Cash Equivalents, at Carrying Value $ 430,241 $ 763,404 $ 790,725